Vildagliptin API Manufactured by GMP Manufacturers

• Customization: Available
• Function: Vitamins and Minerals Deficiency Drug, Original Drug Resistant Microbes, Antipyretic Analgesic and Non-Steroidal Anti-Inflammatory Analgesic, Specialist Drugs, Regulating Water and Salt, Electrolyte and Acid-Base Balance of Medicine, Drug Detoxification, Diagnostic Agents, Anesthetic and Adjuvant, Nervous System Drugs, Enzymes and Other Biochemical, Visceral System Medication, Respiratory System Agents
• Certification: GMP, Reach, FDA
• Model NO.: Customized on demand
• Grade Standard: Medicine Grade
• Type: Chemical Reagent
• State: Solid
• Volatile: Not Volatile
• Molecular Formula: C17h25n3o2
• Transport Package: According to Customer Requirements
• Specification: Customized on demand
• Trademark: none
• Origin: China

Product Description

Vildagliptin is another orally administered dipeptidyl peptidase-IV (DPP-IV) inhibitor after sitagliptin. Approved in the European Union for the treatment of type 2 diabetes. Diabetes mellitus is a chronic metabolic disease, and its prevalence is increasing year by year. Type 2 diabetes is a complex disease caused by the combined effects of multiple genetic factors and environmental factors. Dipeptidyl peptidase IV (DPP-IV) Chemicalbook inhibitors are a new class of anti-diabetic drugs that induce and promote biosynthesis and secretion, inhibit β-cell apoptosis, inhibit glucagon secretion, and reduce food intake, etc. A variety of mechanisms play a role in lowering blood sugar, and while controlling blood sugar, it can reverse the continuous deterioration of islet function in diabetic patients, showing a good application prospect. Vildagliptin is a representative drug of dipeptidyl peptidase inhibitor. It has shown good anti-diabetic effect and tolerance in clinical studies, whether alone or in combination with metformin and i*nsulin.